DICER1 Mutations Occur in More Than One-Third of Follicular-Patterned Pediatric Papillary Thyroid Carcinomas and Correlate with a Low-Risk Disease and Female Gender Predilection

ArticleAçık Erişim

Özet

Some pediatric papillary thyroid carcinoma (PPTC) cohorts have suggested a preliminary correlation with respect to DICER1 mutation status and histomorphology in both benign and malignant follicular cell–derived nodules; however, the data regarding correlates of DICER1-related sporadic PPTCs subtyped based on the 2022 WHO classification criteria are largely unavailable. The current study investigated the status of hotspot DICER1 mutations with clinical, histological and outcome features in a series of 56 patients with PPTCs with no clinical or family history of DICER1-related syndromic manifestation. Fifteen (27%) PPTCs harbored BRAF p.V600E. Eight (14%) cases of PPTCs harbored DICER1 mutations with no associated BRAF p.V600E. DICER1 mutations were identified in exons 26 and 27. A novel D1810del (c.5428_5430delGAT) mutation was also detected. We also confirmed the absence of hotspot DICER1 mutations in the matched non-tumor tissue DNA in all 8 DICER1-related PPTCs. The mean age of DICER1-harboring PPTCs was 15.1 (range: 9–18) years whereas the rest of this cohort had a mean age of 14.8 (range 6–18) years. With the exception of one PPTC, all DICER1-related PPTCs were seen in females (female-to-male ratio: 7). The female to male ratio was 3.8 in 48 DICER1-wild type PPTCs. In terms of histological correlates, 5 of 8 (63%) DICER1-mutant PPTCs were invasive encapsulated follicular variant papillary thyroid carcinomas (FVPTCs) including 4 minimally invasive FVPTCs and 1 encapsulated angioinvasive FVPTC, whereas the remaining 3 PPTCs were infiltrative classic papillary thyroid carcinomas (p < 0.05). The incidence of DICER1 mutations was 19.5% in BRAF p.V600E-wild type PPTCs. Sixty-three percent of DICER1 hotspot mutations occurred in invasive encapsulated FVPTCs, and this figure represents 38% of invasive encapsulated FVPTCs. Only one (12%) patient with DICER1-related disease showed a single lymph node with micro-metastasis. Unlike DICER1-wild type patients, no distant metastasis is identified in patients with DICER1-related PPTCs. The current series expands on the surgical epidemiology of somatic DICER1-related PPTCs by correlating the mutation status with the clinicopathological variables. Our findings underscore that female gender predilection and enrichment in low-risk follicular-patterned PTCs are characteristics of DICER1-related PPTCs. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12078Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1007/s12022-022-09736-yYayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorOnder, Semen
dc.contributor.authorMete, Ozgur
dc.contributor.authorYilmaz, Ismail
dc.contributor.authorBayram, Aysel
dc.contributor.authorBagbudar, Sidar
dc.contributor.authorAltay, Ali Yılmaz
dc.contributor.authorIssin, Gizem
dc.contributor.authorTerzi, Neslihan Kaya
dc.contributor.authorIscan, Yalın
dc.contributor.authorSormaz, Ismail Cem
dc.contributor.authorTunca, Fatih
dc.contributor.authorSenyurek, Yasemin Giles
dc.contributor.authorYegen, Gulcin
dc.date.accessioned2026-10-18T20:27:01.785320906Z
dc.date.available2026-10-18T20:27:01.785320906Z
dc.date.issued2022
dc.description.abstractSome pediatric papillary thyroid carcinoma (PPTC) cohorts have suggested a preliminary correlation with respect to DICER1 mutation status and histomorphology in both benign and malignant follicular cell–derived nodules; however, the data regarding correlates of DICER1-related sporadic PPTCs subtyped based on the 2022 WHO classification criteria are largely unavailable. The current study investigated the status of hotspot DICER1 mutations with clinical, histological and outcome features in a series of 56 patients with PPTCs with no clinical or family history of DICER1-related syndromic manifestation. Fifteen (27%) PPTCs harbored BRAF p.V600E. Eight (14%) cases of PPTCs harbored DICER1 mutations with no associated BRAF p.V600E. DICER1 mutations were identified in exons 26 and 27. A novel D1810del (c.5428_5430delGAT) mutation was also detected. We also confirmed the absence of hotspot DICER1 mutations in the matched non-tumor tissue DNA in all 8 DICER1-related PPTCs. The mean age of DICER1-harboring PPTCs was 15.1 (range: 9–18) years whereas the rest of this cohort had a mean age of 14.8 (range 6–18) years. With the exception of one PPTC, all DICER1-related PPTCs were seen in females (female-to-male ratio: 7). The female to male ratio was 3.8 in 48 DICER1-wild type PPTCs. In terms of histological correlates, 5 of 8 (63%) DICER1-mutant PPTCs were invasive encapsulated follicular variant papillary thyroid carcinomas (FVPTCs) including 4 minimally invasive FVPTCs and 1 encapsulated angioinvasive FVPTC, whereas the remaining 3 PPTCs were infiltrative classic papillary thyroid carcinomas (p < 0.05). The incidence of DICER1 mutations was 19.5% in BRAF p.V600E-wild type PPTCs. Sixty-three percent of DICER1 hotspot mutations occurred in invasive encapsulated FVPTCs, and this figure represents 38% of invasive encapsulated FVPTCs. Only one (12%) patient with DICER1-related disease showed a single lymph node with micro-metastasis. Unlike DICER1-wild type patients, no distant metastasis is identified in patients with DICER1-related PPTCs. The current series expands on the surgical epidemiology of somatic DICER1-related PPTCs by correlating the mutation status with the clinicopathological variables. Our findings underscore that female gender predilection and enrichment in low-risk follicular-patterned PTCs are characteristics of DICER1-related PPTCs. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
dc.identifier.doi10.1007/s12022-022-09736-y
dc.identifier.endpage445
dc.identifier.issn1046-3976
dc.identifier.issue4
dc.identifier.pmid36251117
dc.identifier.scopus2-s2.0-85140042039
dc.identifier.startpage437
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12078
dc.identifier.volume33
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofEndocrine Pathology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBRAF p.V600E
dc.subjectDICER1
dc.subjectDifferentiated thyroid carcinoma
dc.subjectFollicular adenoma
dc.subjectFollicular nodular disease
dc.subjectMultinodular hyperplasia
dc.subjectPapillary thyroid carcinoma
dc.subjectPediatric papillary thyroid carcinoma
dc.subjectPediatric thyroid carcinoma
dc.subjectAdenocarcinoma, Follicular
dc.subjectAdolescent
dc.subjectChild
dc.subjectDEAD-box RNA Helicases
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMutation
dc.subjectProto-Oncogene Proteins B-raf
dc.subjectRibonuclease III
dc.subjectThyroid Cancer, Papillary
dc.subjectThyroid Neoplasms
dc.subjectDNA
dc.subjectglutamic acid
dc.subjectvaline
dc.subjectB Raf kinase
dc.subjectDEAD box protein
dc.subjectDICER1 protein, human
dc.subjectadult
dc.subjectArticle
dc.subjectBRAF gene
dc.titleDICER1 Mutations Occur in More Than One-Third of Follicular-Patterned Pediatric Papillary Thyroid Carcinomas and Correlate with a Low-Risk Disease and Female Gender Predilection
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus33
rdl.departmentDepartment of Pathology, Mengucek Gazi Education & Research Hospital, Erzincan University, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexPUBMED